JSM 2012 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program HomeActivity Details
|
|||
342 * | Tue, 7/31/2012, 10:30 AM - 12:20 PM | CC-Room 28A | |
Planning and Analysis of Phase I/II Clinical Trials — Contributed Papers | |||
Biopharmaceutical Section | |||
Chair(s): Grace Liu, Johnson & Johnson | |||
10:35 AM | A Time-to-Event Generalized Continual Reassessment Method for Two-Agent Phase I Trials — Nan Jia, University of Michigan ; Thomas M Braun, University of Michigan | ||
10:50 AM | Posterior Probability of Adverse Events (AE) Categories for Phase I Studies — Kyounghwa Bae, Alcon Laboratories ; John W. Seaman III, PhD, Alcon Laboratories ; Mark VonTress, Alcon Laboratories | ||
11:05 AM | Optimal Dose finding for Phase I Cancer Clinical Trials — Shanhong Guan, Sanofi | ||
11:20 AM | Continual Reassessment Method: A Unified Approach — Keying Ye, The University of Texas at San Antonio ; Xiaobin Yang, Analytic Focus, LLC ; Ying Ji, The University of Texas at San Antonio | ||
11:35 AM | Flexible Link Continual Reassessment Methods for Trivariate Binary Outcome Phase I/II Trials — Wei Zhong, University of Minnesota ; Bradley P Carlin, University of Minnesota ; Joseph S Koopmeiners, University of Minnesota | ||
11:50 AM | Power Calculations Conditioned on a Given Effect Size: Can We Do Better? — Peter Hu, Bristol-Myers Squibb ; Ih Chang, Bristol-Myers Squibb | ||
12:05 PM | Floor Discussion |
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.